Pluristem Stock Fundamentals
| PSTIDelisted Stock | USD 0.67 0.02 2.90% |
Pluristem fundamentals help investors to digest information that contributes to Pluristem's financial success or failures. It also enables traders to predict the movement of Pluristem Stock. The fundamental analysis module provides a way to measure Pluristem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pluristem stock.
Pluristem |
Pluristem Company Return On Equity Analysis
Pluristem's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Pluristem Return On Equity | -86.55 |
Most of Pluristem's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pluristem is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Pluristem has a Return On Equity of -86.55. This is 261.08% higher than that of the Healthcare sector and 137.38% higher than that of the Biotechnology industry. The return on equity for all United States stocks is notably higher than that of the company.
Pluristem Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pluristem's current stock value. Our valuation model uses many indicators to compare Pluristem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pluristem competition to find correlations between indicators driving Pluristem's intrinsic value. More Info.Pluristem is considered to be number one stock in return on equity category among related companies. It is considered to be number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Pluristem by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Pluristem's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pluristem's earnings, one of the primary drivers of an investment's value.Pluristem Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pluristem's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pluristem could also be used in its relative valuation, which is a method of valuing Pluristem by comparing valuation metrics of similar companies.Pluristem is currently under evaluation in return on equity category among related companies.
Pluristem Fundamentals
| Return On Equity | -86.55 | |||
| Return On Asset | -37.35 | |||
| Current Valuation | 4.25 M | |||
| Shares Outstanding | 32.1 M | |||
| Shares Owned By Insiders | 7.28 % | |||
| Shares Owned By Institutions | 12.80 % | |||
| Number Of Shares Shorted | 391.4 K | |||
| Price To Earning | (5.93) X | |||
| Price To Book | 0.63 X | |||
| Price To Sales | 137.18 X | |||
| Revenue | 234 K | |||
| Gross Profit | 23 K | |||
| EBITDA | (46.05 M) | |||
| Net Income | (46.8 M) | |||
| Cash And Equivalents | 61.98 M | |||
| Cash Per Share | 1.92 X | |||
| Total Debt | 30.86 M | |||
| Debt To Equity | 0.77 % | |||
| Current Ratio | 8.22 X | |||
| Book Value Per Share | 1.59 X | |||
| Cash Flow From Operations | (37.67 M) | |||
| Short Ratio | 3.35 X | |||
| Earnings Per Share | (1.58) X | |||
| Number Of Employees | 153 | |||
| Beta | 1.91 | |||
| Market Capitalization | 32.1 M | |||
| Total Asset | 45.94 M | |||
| Retained Earnings | (77.9 K) | |||
| Working Capital | 29.82 M | |||
| Current Asset | 35.6 M | |||
| Current Liabilities | 5.78 M | |||
| Z Score | -2.7 |
About Pluristem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pluristem's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pluristem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pluristem based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Pluristem Therapeutics Inc. operates as a bio-technology company. Pluristem Therapeutics Inc. was incorporated in 2001 and is based in Haifa, Israel. Pluristem Therapeutics operates under Biotechnology classification in the United States and is traded on NGM Exchange. It employs 153 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pluristem in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pluristem's short interest history, or implied volatility extrapolated from Pluristem options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pluristem using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Pluristem Stock
If you are still planning to invest in Pluristem check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pluristem's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |